Dublin, July 21, 2020 (GLOBE NEWSWIRE) -- The "Global Cardiac Marker Analyzer Market, Product Analysis, Companies Business & Marketing Strategy, Major Deals" report has been added to ...

The reagents & kits segment is expected to register the highest growth rate with 11%. Troponin I & T leads the market with a share of 40.3% in 2025. Lab tests accounted for the largest market share of ...

DUBLIN--(BUSINESS WIRE)--The "Cardiac Marker Testing Market by Product (Reagent, Instrument), Component (Troponin I & T, CK-MB, Myoglobin, BNP, hs-CRP), Disease ...

In adults with diabetes, baseline plasma B-type natriuretic peptide (BNP) levels predicted a sustained decline of at least 30% in estimated glomerular filtration rate (eGFR). A clinical model ...

High blood levels of troponin, a protein released by injured heart muscle, can tell whether someone recently experienced a heart attack. Measuring lower, but still problematic, levels of troponin can ...

Please provide your email address to receive an email when new articles are posted on . Elevated levels of cardiac biomarkers were indicative of future cancer risk. The association between biomarkers ...

Last year, researchers Tobias Cronberg and Niklas Mattsson at Lund University in Sweden published a study showing serum tau levels to be a new and promising marker for identifying patients with severe ...

Every year, 4 million new cases of cancer are diagnosed in Europe. Advances in cancer treatment sometimes come at the cost of major adverse effects, and one of the most prominent is cardiotoxicity.

HFpEF, a significant and common health burden that is increasing in prevalence, is associated with an elevated risk of SCD. In a retrospective analysis of data from the TOPCAT study, researchers ...

Researchers have identified a very early marker of cardiac damage in patients undergoing therapy with anthracyclines, a family of drugs commonly used to treat cancer. This finding will enable the ...